The letter about from the sensitivity and specificity of the test in COVID-19 used saliva specimens written by Dr. Kodana was accepted in J of Infection.
The letter about from the sensitivity and specificity of the test in COVID-19 used saliva specimens written by Dr. Kodana was accepted in J of Infection.
The original article reported by Dr. Kubota was published in Diagn Microbiol Infect Dis.
K. Kubota , Y. Kitagawa , M. Matsuoka , K. Imai , Y. Orihara , R. Kawamur, J. Sakai , N. Ishibashi , N. Tarumoto , S. Takeuchi , S. Maesaki , T. Maeda.
Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays. 【Pubmed】
The original article reported by Dr. Imai was published in J Med Virol. 「Antibody response patterns in COVID-19 patients with different levels of disease severity-Japan.」Imai K, Kitagawa Y, Tabata S, Kubota K, Nagura-Ikeda M, Matsuoka M, Miyoshi K, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S, Ito T, Maesaki S, Tamura K, Maeda T.【PubMed】
The original article reported by Dr. Tarumoto titled ‘A novel peptide nucleic acid-mediated loop-mediated isothermal amplification assay for the detection of mutations in the 23S rRNA gene of Treponema pallidum‘ was accepted in J Med Microbiol.【PubMed】
Norihito Tarumoto, Kazuo Imai , Shu-Ichi Nakayama , Ichiro Itoda, Jun Sakai, Takashi Murakami, Shigefumi Maesaki, Satoshi Hayakawa, Makoto Ohnishi, Takuya Maeda.
The original article reported by Dr. Imai titled ‘Optimization and evaluation of the ARCHITECT Chagas assay and in-house ELISA for Chagas disease in clinical settings in Japan.’ was accepted in Parasitology International【PubMed】
Kazuo Imai , Takashi Murakami , Kazuhisa Misawa , Yuji Fujikura , Akihiko Kawana , Norihito Tarumoto , Shigefumi Maesaki , Takuya Maeda. Optimization and evaluation of the ARCHITECT Chagas assay and in-house ELISA for Chagas disease in clinical settings in Japan.
The original article corresponding with Dr. Imai was published in Lancet Infect Dis.
Author links open overlay panel
The paper reported by Dr. Fkada titled ‘Presepsin as a predictive biomarker of severity in COVID-19: a case series.’ was accepted in Journal of Medical Virology.【PubMed】
Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, Orihara Y, Kawamura R, Takeuchi S, Maesaki S, Maeda T. Presepsinas a predictive biomarker of severity in COVID-19: a case series.
The original article by Dr. Sakai entitled Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection was accepted in Journal of Hospital Infection.【PubMed】
The original article by Ms. Ogane was accepted in Anaerobe.
Kana Ogane, Norihito Tarumoto,Masahiro Kodana, Azusa Onodera, Kazuo Imai,Jun Sakai,Toru Kawamura, Shinichi Takeuchi, Takashi Murakami, Kotaro Mitsutake, Kenji Ikebuchi, Shigefumi Maesaki, Takuya Maeda. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.【PubMed】
The original article reported by Mr. Kitagawa was accepted in J Clin Virol.
Yutaro Kitagawa, et al. Evaluation of rapid diagnosis of novel coronavirus diseases (COVID-19) using a loop-mediated isothermal amplification method. J Clin Virol 【PubMed】